{"entity":{"type":"insider","cik":"0001456656","url":"/insider/0001456656","json_url":"/insider/0001456656.json","name":"Frazier Healthcare VI, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":6,"first":"2009-02-20","last":"2017-11-06","span_basis":"filed_date"},"name_variants":[{"name":"Frazier Healthcare VI, L.P.","source":"filing","n_filings":6,"first_seen":"2009-02-20","last_seen":"2017-11-06"}],"transactions":[{"id":4833370,"accession":"0001209191-17-059504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-059504","line_url":"/filing/0001209191-17-059504#line-2","is_derivative":false,"issuer_cik":"0001456654","issuer_name":"Allena Pharmaceuticals, Inc.","issuer_ticker":"ALNA","issuer_name_source":null,"issuer_url":"/issuer/0001456654","owner_cik":null,"owner_name":"FHM VI, L.L.C.; FHM VI, L.P.; Frazier Healthcare VI, L.P.","owner_display_name":"FHM VI, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":3330373.0,"shares_owned_after_display":"3,330,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-06","filed_date":"2017-11-06","scope":"insider"},{"id":8782859,"accession":"0001192482-15-000206","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001192482-15-000206","line_url":"/filing/0001192482-15-000206#line-5","is_derivative":false,"issuer_cik":"0001018534","issuer_name":"COLLEGIUM PHARMACEUTICAL, INC","issuer_ticker":"COLL","issuer_name_source":null,"issuer_url":"/issuer/0001018534","owner_cik":null,"owner_name":"Frazier Healthcare VI, L.P.; FHM VI, L.L.C.; Every Nathan R; FHM VI, L.P.; Topper James N; Naini Nader J; FRAZIER ALAN D","owner_display_name":"Frazier Healthcare VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":1800000.0,"total_display":"1,800,000.00","total_whole":"1,800,000","shares_owned_after":1887332.0,"shares_owned_after_display":"1,887,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-14","scope":"insider"},{"id":2191244,"accession":"0001181431-12-011208","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-12-011208","line_url":"/filing/0001181431-12-011208","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"FHM VI, L.P.; Frazier Healthcare VI, L.P.; FHM VI, L.L.C.","owner_display_name":"FHM VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13737243.0,"shares_display":"13,737,243","price_per_share":5.876202831965628,"price_display":"5.88","price_state":"stated","total_value":80722826.22,"total_display":"80,722,826.22","total_whole":"80,722,826","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-21","filed_date":"2012-02-23","scope":"insider","n_lines":6},{"id":3485511,"accession":"0001181431-12-006820","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-006820","line_url":"/filing/0001181431-12-006820","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"Frazier Healthcare VI, L.P.; FHM VI, L.L.C.; FHM VI, L.P.","owner_display_name":"Frazier Healthcare VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900000.0,"shares_display":"900,000","price_per_share":3.02,"price_display":"3.02","price_state":"stated","total_value":2718000.0,"total_display":"2,718,000.00","total_whole":"2,718,000","shares_owned_after":4579081.0,"shares_owned_after_display":"4,579,081","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-07","filed_date":"2012-02-08","scope":"insider","n_lines":3},{"id":9121727,"accession":"0001181431-11-018568","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-018568","line_url":"/filing/0001181431-11-018568","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"THRESHOLD PHARMACEUTICALS INC","issuer_ticker":"THLD","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"FHM VI, L.L.C.; Frazier Healthcare VI, L.P.; FHM VI, L.P.","owner_display_name":"FHM VI, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2857140.0,"shares_display":"2,857,140","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":5857137.0,"total_display":"5,857,137.00","total_whole":"5,857,137","shares_owned_after":4879081.0,"shares_owned_after_display":"4,879,081","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-16","filed_date":"2011-03-16","scope":"insider","n_lines":3},{"id":5700072,"accession":"0001181431-09-010498","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-09-010498","line_url":"/filing/0001181431-09-010498","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":null,"owner_name":"FHM VI, L.P.; Frazier Healthcare V, LP; FHM V, LLC; FHM VI, L.L.C.; FHM V, LP; Frazier Healthcare VI, L.P.","owner_display_name":"FHM VI, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10427526.0,"shares_display":"10,427,526","price_per_share":7.13,"price_display":"7.13","price_state":"stated","total_value":74348260.38,"total_display":"74,348,260.38","total_whole":"74,348,260","shares_owned_after":3128258.0,"shares_owned_after_display":"3,128,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-18","filed_date":"2009-02-20","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001624658","name":"Allena Pharmaceuticals, Inc.","url":"/issuer/0001624658","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-06","last_seen":"2017-11-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Ten percent owner","n_filings":1,"first_seen":"2015-05-14","last_seen":"2015-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"THRESHOLD PHARMACEUTICALS INC","url":"/issuer/0001183765","role":"Ten percent owner","n_filings":3,"first_seen":"2011-03-16","last_seen":"2012-02-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":1,"first_seen":"2009-02-20","last_seen":"2009-02-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001456656","retrieved_at":"2026-08-25T10:56:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}